Literature DB >> 27359286

MicroRNA-210 and its theranostic potential.

Chun-Xia Ren1,2,3, Rui-Xue Leng1,2, Yin-Guang Fan1,2, Hai-Feng Pan1,2, Chang-Hao Wu4, Dong-Qing Ye1,2.   

Abstract

INTRODUCTION: MicroRNAs (miRNAs) are a set of small single-stranded noncoding RNAs with diverse biological functions. As a prototypical hypoxamir, human microRNA-210 (hsa-miR-210) is one of the most widely studied miRNAs thus far. In addition to its involvement in sophisticated regulation of numerous biological processes, miR-210 has also been shown to be associated with the development of different human diseases including various types of cancers, cardiovascular and cerebrovascular diseases, and immunological diseases. Given its multi-faceted functions, miR-210 may serve as a novel and promising theranostic target for prevention and treatment of diseases. Areas covered: This review aims to provide a comprehensive overview of miR-210, the regulation of its expression, biological functions and molecular mechanisms, with particular emphasis on its diagnostic and therapeutic potential. Expert opinion: Although the exact roles of miR-210 in various diseases have not been fully clarified, targeting miR-210 may be a promising therapeutic strategy. Further investigations are also needed to facilitate therapeutic-clinical applications of miR-210 in human diseases.

Entities:  

Keywords:  MicroRNA-210; biomarker; hypoxia; theranostic target

Mesh:

Substances:

Year:  2016        PMID: 27359286     DOI: 10.1080/14728222.2016.1206890

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  6 in total

Review 1.  Reciprocal regulations between miRNAs and HIF-1α in human cancers.

Authors:  Wanli Yang; Jiaojiao Ma; Wei Zhou; Bo Cao; Xin Zhou; Hongwei Zhang; Qingchuan Zhao; Liu Hong; Daiming Fan
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

2.  Exosomal microRNA-210 is a potentially non-invasive biomarker for the diagnosis and prognosis of glioma.

Authors:  Fengming Lan; Xiao Yue; Tingyi Xia
Journal:  Oncol Lett       Date:  2020-01-07       Impact factor: 2.967

3.  MNT and Emerging Concepts of MNT-MYC Antagonism.

Authors:  Guang Yang; Peter J Hurlin
Journal:  Genes (Basel)       Date:  2017-02-20       Impact factor: 4.096

4.  Circulating exosomal microRNAs as novel potential detection biomarkers in pancreatic cancer.

Authors:  Lun Wu; Wen-Bo Zhou; Jiao Zhou; Ying Wei; Hong-Mei Wang; Xian-De Liu; Xiao-Chun Chen; Wei Wang; Lin Ye; Li Chao Yao; Qin-Hua Chen; Zhi-Gang Tang
Journal:  Oncol Lett       Date:  2020-05-30       Impact factor: 2.967

Review 5.  Noncoding RNAs Emerging as Drugs or Drug Targets: Their Chemical Modification, Bio-Conjugation and Intracellular Regulation.

Authors:  Jin Wang; Tian Tian; Xin Li; Yan Zhang
Journal:  Molecules       Date:  2022-10-09       Impact factor: 4.927

6.  MicroRNA-210-3p Promotes Chondrogenic Differentiation and Inhibits Adipogenic Differentiation Correlated with HIF-3α Signalling in Bone Marrow Mesenchymal Stem Cells.

Authors:  Meng Yang; Xin Yan; Fu-Zhen Yuan; Jing Ye; Ming-Ze Du; Zi-Mu Mao; Bing-Bing Xu; You-Rong Chen; Yi-Fan Song; Bao-Shi Fan; Jia-Kuo Yu
Journal:  Biomed Res Int       Date:  2021-04-10       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.